The Apex Times
Above the Noise
Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Eli Lilly commits to Veeva Vault CRM for global customer management
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 11, 7:15 AM EDT

Eli Lilly commits to Veeva Vault CRM for global customer management

Veeva Systems said Eli Lilly has committed to deploy Vault CRM globally, indicating continued investment in cloud-based tools that manage sales and customer engagement in life sciences.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Veeva Systems said Eli Lilly has committed to use Veeva Vault CRM on a global basis, a move that expands the role of Veeva’s cloud software in how pharmaceutical companies run customer-facing operations. The announcement, published through Veeva communications and carried by Yahoo Finance, frames the decision as part of Lilly’s broader effort to standardize its commercial and engagement processes across regions.

Veeva Vault CRM is Veeva’s customer relationship management platform tailored for life sciences. In practical terms, CRM tools in the sector are used to support the activities of sales and medical teams, including tracking interactions with healthcare customers, managing account engagement, and aligning materials and workflows with company and regulatory expectations.

The disclosure did not outline timing for the rollout, the size of the deployment, or whether Lilly will implement additional Veeva offerings beyond Vault CRM. It also did not provide performance targets or financial terms tied to the commitment, leaving investors to assess the business impact primarily through Veeva’s general customer momentum and Lilly’s status as a major global pharmaceutical company.

Veeva’s statement positions Lilly’s commitment as a global selection rather than a pilot or limited regional use. For Veeva, global commitments can matter because they often indicate deeper adoption and longer-term software usage, particularly when deployments extend across multiple countries and teams.

For Lilly, adopting a dedicated life sciences CRM platform can be part of managing complexity in a heavily regulated environment, where customer-facing materials and documented interactions must meet internal governance requirements. Standardizing on a single platform across geographies also helps reduce fragmentation between regions and may support consistent analytics and reporting for commercial leadership.

Still, the public announcement leaves key questions unanswered. It does not specify when the company expects to complete implementation, which Lilly business units or geographies will be included first, or whether the platform will integrate with existing Lilly systems for sales, analytics, content, and compliance. Without those details, it is not possible to quantify how quickly the deployment could translate into measurable productivity changes for Lilly or incremental revenue implications for Veeva.

What to watch next is whether Lilly and Veeva provide additional rollout milestones, customer adoption metrics, or commentary in future quarterly updates. Investors will likely look for confirmation that the commitment progresses from selection to implementation and for any mention of related Veeva products that could broaden the relationship beyond CRM.

Why It Matters

  • A global CRM commitment from a large pharmaceutical company underscores continued demand for specialized cloud tools in life sciences sales and engagement.
  • For Veeva, broader global selections can announcement potential for deeper adoption and longer-duration recurring software usage.
  • For Lilly, moving toward a standardized CRM approach may help unify how commercial teams manage customer interactions across regions.

Sources

Key Facts

  • Veeva Systems said Eli Lilly has committed to Veeva Vault CRM globally.
  • The announcement was reported by Yahoo Finance on August 11, 2026.
  • Veeva Vault CRM is positioned as a life sciences-focused CRM platform used to manage customer engagement workflows.
  • No rollout schedule, financial terms, or deployment scope details were included in the reported disclosure.

Healthcare Related

Eli Lilly commits to Veeva Vault CRM for global customer management | The Apex Times